Catalyst Wire Dossier Catalyst Wire Dossier

A/H1N1 swine-origin influenza vaccine (adjuvanted and non-adjuvanted)

· Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A/H1N1 swine-origin influenza vaccine (adjuvanted and non-adjuvanted), covering 2020-02-11 to 2020-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age [Phase 3]

See pricing